Monsanto closes $300M sale of cow growth hormone brand

10/2/2008 | Forbes

Monsanto has finalized the $300 million sale of Posilac, a cow growth hormone brand, to Eli Lilly and Co. The transaction is in line with Monsanto's long-term plan to concentrate on marketing high-tech seeds to farmers throughout the world.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR